Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 30.08.17 in Vol 6, No 8 (2017): August

This paper is in the following e-collection/theme issue:

Works citing "Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.7186):

(note that this is only a small subset of citations)

  1. Johnson TP, Sejvar J, Nutman TB, Nath A. The Pathogenesis of Nodding Syndrome. Annual Review of Pathology: Mechanisms of Disease 2020;15(1):395
    CrossRef
  2. Hotterbeekx A, Dusabimana A, Mandro M, Abhafule GM, Deogratias W, Siewe Fodjo JN, Abrams S, Colebunders R. Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy. Pathogens 2020;9(3):191
    CrossRef
  3. Walker M, Hamley JID, Milton P, Monnot F, Pedrique B, Basáñez M. Designing antifilarial drug trials using clinical trial simulators. Nature Communications 2020;11(1)
    CrossRef
  4. Velghe S, Delahaye L, Ogwang R, Hotterbeekx A, Colebunders R, Mandro M, Idro R, Stove CP. Dried Blood Microsampling-Based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children With Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo. Therapeutic Drug Monitoring 2020;42(3):481
    CrossRef
  5. Mandro M, Siewe Fodjo JN, Mukendi D, Dusabimana A, Menon S, Haesendonckx S, Lokonda R, Nakato S, Nyisi F, Abhafule G, Wonya’Rossi D, Jakwong JM, Suykerbuyk P, Meganck J, Hotterbeekx A, Colebunders R, Goletti D. Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial. PLOS Neglected Tropical Diseases 2020;14(1):e0007966
    CrossRef
  6. Siewe Fodjo JN, Dekker MCJ, Idro R, Mandro MN, Preux P, Njamnshi AK, Colebunders R. Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys. Infectious Diseases of Poverty 2019;8(1)
    CrossRef
  7. Stacey HJ, Woodhouse L, Welburn SC, Jones JD. Aetiologies and therapies of nodding syndrome: a systematic review and meta-analysis. Journal of Global Health Reports 2019;3
    CrossRef
  8. Siewe Fodjo JN, Mandro M, Wonya'rossi D, Inaç Y, Ngave F, Lokonda R, Anyolito A, Verelst F, Colebunders R. Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo. EClinicalMedicine 2019;9:60
    CrossRef
  9. Siewe Fodjo JN, Mandro M, Mukendi D, Tepage F, Menon S, Nakato S, Nyisi F, Abhafule G, Wonya’rossi D, Anyolito A, Lokonda R, Hotterbeekx A, Colebunders R, Wanji S. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density. PLOS Neglected Tropical Diseases 2019;13(7):e0007300
    CrossRef
  10. Colebunders R, Mandro M, Njamnshi AK, Boussinesq M, Hotterbeekx A, Kamgno J, O’Neill S, Hopkins A, Suykerbuyk P, Basáñez M, Post RJ, Pedrique B, Preux P, Stolk WA, Nutman TB, Idro R. Report of the first international workshop on onchocerciasis-associated epilepsy. Infectious Diseases of Poverty 2018;7(1)
    CrossRef
  11. Colebunders R, Nelson Siewe F, Hotterbeekx A. Onchocerciasis-Associated Epilepsy, an Additional Reason for Strengthening Onchocerciasis Elimination Programs. Trends in Parasitology 2018;34(3):208
    CrossRef
  12. Vinkeles Melchers NVS, Mollenkopf S, Colebunders R, Edlinger M, Coffeng LE, Irani J, Zola T, Siewe JN, de Vlas SJ, Winkler AS, Stolk WA. Burden of onchocerciasis-associated epilepsy: first estimates and research priorities. Infectious Diseases of Poverty 2018;7(1)
    CrossRef